Aktuelle Urol 2013; 44(05): 381-382
DOI: 10.1055/s-0033-1345147
Case Report
© Georg Thieme Verlag KG Stuttgart · New York

Malignant Bladder Pheochromocytoma with SDHB Genetic Mutation

Malignes Phäochromozytom der Blase mit genetischer SDHB Mutation
M. Maeda
1   Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan
,
Y. Funahashi
1   Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan
,
M. Katoh
1   Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan
,
T. Fujita
1   Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan
,
K. Tsuruta
1   Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan
,
M. Gotoh
1   Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2013 (online)

Abstract

A 30-year-old man presented with micturition pain and was diagnosed with a submucosal tumor in the right wall of the bladder with metastasis to the right obturator lymph node. Transurethral resection led to a diagnosis of invasive malignant pheochromocytoma. Radical cystectomy, neobladder reconstruction and bilateral iliac lymph node dissection were performed. Genetic analysis revealed succinate dehydrogenase B-associated hereditary pheochromocytoma/paraganglioma syndrome. 10 months after the operation, he had no evidence of recurrence.

Zusammenfassung

Ein 30-jähriger Mann stellte sich mit Miktions­schmerz vor. Es wurde ein submukosaler Tumor in der rechten Blasenwand mit Metastasierung in die rechten Obturator-Lymphknoten diagnostiziert. Die transurethrale Tumorresektion ergab die Diagnose eines invasiven malignen Phäochromozytoms. In Folge wurden eine radikale Zystektomie, eine Neoblasen-Rekonstruktion und bilaterale iliakale Lymphknoten Dissektionen durchgeführt. Die genetische Analyse zeigte ein Succinatdehydrogenase B assoziiertes Phäochromozytom/Paragangliom Syndrom. 10 Monate nach der Operation ergab sich kein Hinweis auf ein Rezidiv.

 
  • References

  • 1 Whalen RK, Althausen AF, Daniels GH. Extra-adrenal pheochromocytoma. J Urol 1992; 147: 1-10
  • 2 Thrasher JB, Rajan RR, Perez LM et al. Pheochromocytoma of urinary bladder: contemporary methods of diagnosis and treatment options. Urology 1993; 41: 435-439
  • 3 Manger WM, Grifford Jr RW, Hoffman BB. Pheochromocytoma: a clinical and experimental overview. Curr Probl Cancer 1985; 9: 1-89
  • 4 Timmers HJ, Kozupa A, Chen CC et al. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. J Clin Oncol 2007; 25: 2262-2269
  • 5 Kirmani S, Young WF. Hereditary Paraganglioma-Pheochromocytoma Syndromes. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP. (eds.). GeneReviews™ [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2008 [updated 2012 Aug 30]
  • 6 Gimenez-Roqueplo AP, Favier J, Rustin P et al. COMETE Network. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant pheochromocytomas. Cancer Res 2003; 63: 5615-5621
  • 7 Amar L, Baudin E, Burnichon N et al. Succinate dehytrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J Clin Endocrinol Metab 2007; 92: 3822-3828